Multi-cohort Study of Surufatinib Plus Sintilimab in Metastatic NEN and Pancreatic Carcinoma Who Failed Standard Chemotherapy
Tianjin Medical University Cancer Institute and Hospital
Tianjin Medical University Cancer Institute and Hospital
Provectus Pharmaceuticals
SpeciCare
Royal Free Hospital NHS Foundation Trust
American College of Radiology Imaging Network
Istituto Clinico Humanitas
National Cancer Institute (NCI)